This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Buy These 5 Hated Stocks to Beat the S&P

Stocks in this article: PXD CERN CRM BDX SWK

Cerner

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Cerner (CERN) is another heavily shorted medical stock worth watching right now. The firm is focused on harnessing the tailwinds from the transition to digital medical records. Cerner's Millennium software platform is marketed to everyone from pharmacists to physicians as a holistic approach to patient management, from medical data to financial records.

A big tailwind for Cerner is the fact that the U.S. government has mandated that medical facilities switch to electronic records -- and it's chipping in billions of dollars of subsidies to make it happen. Cerner's software also helps streamline the administrative side of things for medical providers, in some cases shortening the lag from when services are performed to when practices get paid. That adds some extra incentive for professionals to install Millennium in their offices.

With those big incentives in place, it's no surprise that around 80% of Cerner's sales come from the U.S. But the firm also has some attractive growth opportunities abroad, even if they're a less central part of the firm's long-term strategy. Exceptionally high customer switching costs and a bigger pool of potential clients in the coming years should help keep Cerner's top line on its upward trajectory.

Meanwhile, a short interest ratio of 12.8 makes this stock a solid short squeeze candidate from here.

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs